A citation-based method for searching scientific literature

Jorge Zeron-Medina, Maria Ochoa de Olza, Irene Braña, Jordi Rodon. Semin Oncol 2015
Times Cited: 5







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Immunopathology of synovitis: from histology to molecular pathways.
Marleen G van de Sande, Dominique L Baeten. Rheumatology (Oxford) 2016
24
20

Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials.
Frances Humby, Stephen Kelly, Rebecca Hands, Vidalba Rocher, Maria DiCicco, Nora Ng, Lu Zou, Serena Bugatti, Antonio Manzo, Roberto Caporali,[...]. Arthritis Rheumatol 2015
30
20

Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients.
S Kelly, F Humby, A Filer, N Ng, M Di Cicco, R E Hands, V Rocher, M Bombardieri, M A D'Agostino, I B McInnes,[...]. Ann Rheum Dis 2015
101
20

Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation Requirements.
Frances Humby, Stephen Kelly, Serena Bugatti, Antonio Manzo, Andrew Filer, Arti Mahto, Joao Eurico Fonseca, Bernard Lauwerys, Maria-Antonietta D'Agostino, Esperanza Naredo,[...]. J Rheumatol 2016
21
20

Success Rate and Utility of Ultrasound-guided Synovial Biopsies in Clinical Practice.
Aurélie Najm, Carl Orr, Marie-Françoise Heymann, Géraldine Bart, Douglas J Veale, Benoît Le Goff. J Rheumatol 2016
20
20


Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability.
Bart V J Cuppen, Paco M J Welsing, Jan J Sprengers, Johannes W J Bijlsma, Anne C A Marijnissen, Jacob M van Laar, Floris P J G Lafeber, Sandhya C Nair. Rheumatology (Oxford) 2016
49
20

How to perform and analyse synovial biopsies.
Daniëlle M Gerlag, Paul P Tak. Best Pract Res Clin Rheumatol 2013
22
20

Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis.
Jasper J Haringman, Marjolein Vinkenoog, Danielle M Gerlag, Tom J M Smeets, Aeilko H Zwinderman, Paul P Tak. Arthritis Res Ther 2005
68
20

Ultrasound-guided synovial biopsy: a systematic review according to the OMERACT filter and recommendations for minimal reporting standards in clinical studies.
Ilias Lazarou, Maria-Antonietta D'Agostino, Esperanza Naredo, Frances Humby, Andrew Filer, Stephen G Kelly. Rheumatology (Oxford) 2015
15
20

Remission in early rheumatoid arthritis.
Margaret H Y Ma, Ian C Scott, Gabrielle H Kingsley, David L Scott. J Rheumatol 2010
55
20


Epigenetics in rheumatoid arthritis: a primer for rheumatologists.
Nunzio Bottini, Gary S Firestein. Curr Rheumatol Rep 2013
45
20


Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker.
Carla A Wijbrandts, Clarissa E Vergunst, Jasper J Haringman, Danielle M Gerlag, Tom J M Smeets, Paul P Tak. Arthritis Rheum 2007
83
20

Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.
Maarten C Kraan, Richard J Reece, Tom J M Smeets, Douglas J Veale, Paul Emery, Paul P Tak. Arthritis Rheum 2002
128
20

Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritis.
Maria J H de Hair, Leonard C Harty, Danielle M Gerlag, Costantino Pitzalis, Douglas J Veale, Paul P Tak. J Rheumatol 2011
31
20


The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Kaarina Kowalec, Bruce Carleton, Helen Tremlett. Mult Scler Relat Disord 2013
7
20

Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions.
Lydia Abasolo, Leticia Leon, Luis Rodriguez-Rodriguez, Aurelio Tobias, Zulema Rosales, Jose Maria Leal, Victor Castaño, Cristina Vadillo, Pilar Macarron, Oscar Fontsere,[...]. Semin Arthritis Rheum 2015
15
20

Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptoms.
Rik de Greef, Alan Maloney, Per Olsson-Gisleskog, Joep Schoemaker, John Panagides. AAPS J 2011
34
20


Pharmacogenetics goes genomic.
David B Goldstein, Sarah K Tate, Sanjay M Sisodiya. Nat Rev Genet 2003
201
20

Cutaneous side-effects of antihepatitis C treatment: the U.K. experience.
E Orrin, A Barnabas, K Agarwal, S A Walsh. Br J Dermatol 2015
4
25

Promoting adverse drug reaction reporting: comparison of different approaches.
Inês Ribeiro-Vaz, Cristina Costa Santos, Ricardo Cruz-Correia. Rev Saude Publica 2016
9
20

Citizen science or scientific citizenship? Disentangling the uses of public engagement rhetoric in national research initiatives.
J Patrick Woolley, Michelle L McGowan, Harriet J A Teare, Victoria Coathup, Jennifer R Fishman, Richard A Settersten, Sigrid Sterckx, Jane Kaye, Eric T Juengst. BMC Med Ethics 2016
53
20

Pharmacogenetics: past, present and future.
Munir Pirmohamed. Drug Discov Today 2011
50
20

Ask not what personalized medicine can do for you--ask what you can do for personalized medicine.
Isabelle Budin-Ljøsne, Jennifer R Harris. Public Health Genomics 2015
16
20

Personalized Therapy of Small Cell Lung Cancer.
Bryan J Schneider, Gregory P Kalemkerian. Adv Exp Med Biol 2016
19
20

Development and clinical application of an integrative genomic approach to personalized cancer therapy.
Andrew V Uzilov, Wei Ding, Marc Y Fink, Yevgeniy Antipin, Andrew S Brohl, Claire Davis, Chun Yee Lau, Chetanya Pandya, Hardik Shah, Yumi Kasai,[...]. Genome Med 2016
52
20

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.
M R Nelson, S-A Bacanu, M Mosteller, L Li, C E Bowman, A D Roses, E H Lai, M G Ehm. Pharmacogenomics J 2009
65
20

Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study.
Gary E Marchant, Kathryn Scheckel, Doug Campos-Outcalt. J Law Med Ethics 2016
6
20



Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.
Stuart C Gordon, Andrew J Muir, Joseph K Lim, Brian Pearlman, Curtis K Argo, Ananthakrishnan Ramani, Benedict Maliakkal, Imtiaz Alam, Thomas G Stewart, Monika Vainorius,[...]. J Hepatol 2015
77
20

Pharmacogenomics of biological treatment in rheumatoid arthritis.
Xi Xie, David Zhang, Jin-wei Chen, Jing Tian, Guang-hui Ling, Fen Li. Expert Opin Biol Ther 2014
7
20

H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine.
Marina Borro, Maurizio Simmaco, Antonio Aceti, Sandro Barni, Assunta De Luca, Vittorio Fineschi, Paola Frati, Paolo Girardi, Monica Miozzo, Giulio Nati,[...]. Curr Pharm Biotechnol 2016
8
20


Precision oncology: origins, optimism, and potential.
Vinay Prasad, Tito Fojo, Michael Brada. Lancet Oncol 2016
106
20


Patient and interest organizations' views on personalized medicine: a qualitative study.
Isabelle Budin-Ljøsne, Jennifer R Harris. BMC Med Ethics 2016
19
20



Prediction of severe adverse drug reactions using pharmacogenetic biomarkers.
Masahiro Tohkin, Akihiro Ishiguro, Nahoko Kaniwa, Yoshiro Saito, Kouichi Kurose, Ryuichi Hasegawa. Drug Metab Pharmacokinet 2010
20
20

Personalized medicine: is it a pharmacogenetic mirage?
Rashmi R Shah, Devron R Shah. Br J Clin Pharmacol 2012
43
20

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Goeril Karlsson, Gordon Francis, Gideon Koren, Peter Heining, Xiaoli Zhang, Jeffrey A Cohen, Ludwig Kappos, William Collins. Neurology 2014
95
20

Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
Stefano Piermarocchi, Stefania Miotto, Davide Colavito, Alberta Leon, Tatiana Segato. Acta Ophthalmol 2015
21
20

Frequency and cost of serious adverse drug reactions in a department of general medicine.
N Moore, D Lecointre, C Noblet, M Mabille. Br J Clin Pharmacol 1998
188
20

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients.
Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Shuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka. Mod Rheumatol 2012
55
20

Drug reactions enzymes, and biochemical genetics.
A G MOTULSKY. J Am Med Assoc 1957
240
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.